LCTX

LCTX Total Assets

$106.22MQuarterly · USD

Period ending:

LCTX FY Total AssetsUSD
LCTX FY Total Assets1992-06-30: $4.80M1993-06-30: $3.50M1994-06-30: $5.90M1995-06-30: $3.60M1996-06-30: $3.00M1998-06-30: $6.70M1998-12-31: $2.80M1999-12-31: $5.68M2000-12-31: $1.68M2001-12-31: $1.94M2002-12-31: $1.50M2003-12-31: $1.07M2004-12-31: $1.52M2005-12-31: $1.96M2006-12-31: $650.51K2007-12-31: $175.10K2008-12-31: $1.04M2009-12-31: $13.43M2010-12-31: $53.27M2011-12-31: $45.83M2012-12-31: $29.75M2013-12-31: $57.73M2014-12-31: $74.90M2015-12-31: $94.66M2016-12-31: $142.57M2017-12-31: $173.24M2018-12-31: $101.66M2019-12-31: $125.48M2020-12-31: $107.95M2021-12-31: $174.55M2022-12-31: $123.66M2023-12-31: $101.02M2024-12-31: $113.22M2025-12-31: $112.58M$174.55M$0.00
1992-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LCTX total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 34 observations from Jun 30, 1992 to Dec 31, 2025.

Lineage Cell Therapeutics, Inc. Common Stock Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
112,584,000
113,218,000
101,019,000
123,664,000
174,545,000
107,949,000
125,478,000
101,660,000
173,241,000
142,572,000
94,660,000
74,900,906
57,729,750
29,748,593
45,829,695
53,272,659
13,433,071
1,035,457
175,102
650,507
1,958,784
1,521,589
1,071,545
1,496,081
1,941,375
1,677,484
5,678,644
2,800,000
6,700,000
3,000,000
3,600,000
5,900,000
3,500,000
4,800,000

Compare total assets

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.